MedPath

Phase II study of Combination of CPT-11 and S-1 for Advanced Non-Small-cell lung cancer

Not Applicable
Conditions
Previously untreated stageIIIB/IV NSCLC
Registration Number
JPRN-C000000415
Lead Sponsor
West Japan Oncology Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
55
Inclusion Criteria

Not provided

Exclusion Criteria

Symptomatic brain metastasis SVC symdrome

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath